000 01672 a2200457 4500
005 20250514020633.0
264 0 _c20011231
008 200112s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(20011001)92:7<1888::aid-cncr1706>3.0.co;2-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNathan, C A
245 0 0 _aCOX-2 expression in dysplasia of the head and neck: correlation with elF4E.
_h[electronic resource]
260 _bCancer
_cOct 2001
300 _a1888-95 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnticarcinogenic Agents
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aBlotting, Western
650 0 4 _aCarcinoma, Squamous Cell
_xmetabolism
650 0 4 _aCyclooxygenase 2
650 0 4 _aCyclooxygenase 2 Inhibitors
650 0 4 _aCyclooxygenase Inhibitors
_xtherapeutic use
650 0 4 _aHead and Neck Neoplasms
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aIsoenzymes
_xantagonists & inhibitors
650 0 4 _aMembrane Proteins
650 0 4 _aPrecancerous Conditions
_xdrug therapy
650 0 4 _aProstaglandin-Endoperoxide Synthases
_xmetabolism
650 0 4 _aRespiratory Mucosa
_xmetabolism
650 0 4 _aTumor Cells, Cultured
700 1 _aLeskov, I L
700 1 _aLin, M
700 1 _aAbreo, F W
700 1 _aShi, R
700 1 _aHartman, G H
700 1 _aGlass, J
773 0 _tCancer
_gvol. 92
_gno. 7
_gp. 1888-95
856 4 0 _uhttps://doi.org/10.1002/1097-0142(20011001)92:7<1888::aid-cncr1706>3.0.co;2-z
_zAvailable from publisher's website
999 _c11658271
_d11658271